Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.

PINL:GRPOF - Post by User

Traxion Sab De Cv Ord Shs > Game Changers around the corner...

<< Previous

Bullboard Posts

Next >>

Comment by shrinkon Feb 08, 2018 9:46am

100 Views

Post# 27525688

RE:Game Changers around the corner...

Looks like the financing news release is out 8 mill.

LeafRider wrote: Remember what the game changers are with Tetra.

1 - Fiancing deal ($15-20 million) slight dilution to provide Tetra with the horsepower to take PPP001-PPP005 to market. This deal validate the plan ensure that Tetra has the monetary tools to take us to DIN# approvals on more than one drug.

2. - Whatever comes out of the R&D agreement with Constance Therapeutics: This relationship along with Guy Chamberland working the trenches are 2 of the biggest reasons I'm invested with Tetra. They have the knowledge behind the science in place. If something happened to either of these two entities I will likely reduce my holdings. Guy and Constance are the 2 components that set us asside from the US companies we often get compared to. Sure there are stars in companies but these two things places at the Top of cannabinoid drug discovery.

3 - ACMPR late stage license sale and eventual ownership in a maximum 1.5 million sq. ft facility which is what's on the application, this might be a few years out, but this may turn out to be very lucrative for us down the line.

4 - OTC Pharmaceutical partnership - This deal will be announced inside of Q1-2018 - or this side of the busniess is delayed.

5 - Anything that comes out of our relationship with UNB, McGill, etc. etc.... Partnerships for Canadian distribution and drug development will be a part of the business plan. Don't think that Tetra just shuts down their product pipeline, there are big things to come still. This is basically an extension of point 2.

6 - Everything else on the go, AES Envrio, Vet/Pet market (sales)

All for now... The sky isn't falling, the rats of the world play for short scraps, the rest of us invest for real returns. Have a great week folks.